| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/12/2003 | EP1289383A1 Primary composition containing a lipophilic bioactive compound |
| 03/12/2003 | EP1289369A1 Phytonutrient formula for the relief of chronic pain resulting from inflammation |
| 03/12/2003 | EP1289364A1 Stable gabapentin containing more than 2o ppm of chlorine ion |
| 03/12/2003 | EP1263418A4 Cartilage enhancing food supplements and methods of preparing the same |
| 03/12/2003 | EP1196034B1 Antiparasitic formulation |
| 03/12/2003 | EP1181018B1 Ziprasidone suspension |
| 03/12/2003 | EP1135121B1 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain |
| 03/12/2003 | EP1133290B1 Use of inhibitors of acetylcholinesterase for the treatment of deliriums |
| 03/12/2003 | EP1131100B1 Therapeutic compositions for metabolic bone disorders or bone metastases comprising a photosensitizer and a bisphosphonate |
| 03/12/2003 | EP1103252B1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 03/12/2003 | EP1097127B1 Diacylhydrazine derivatives as integrin inhibitors |
| 03/12/2003 | EP1091954B1 Process for producing (8-chloro-3,10-dibromo-6,11-dihydro-5h-benzo 5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidine |
| 03/12/2003 | EP1083895B1 Compositons comprising sclareol or scareolide for the treatment of microbial infections |
| 03/12/2003 | EP1083891B1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 03/12/2003 | EP1075477B1 Novel Benzonaphthyridine-N-oxides |
| 03/12/2003 | EP1044203B1 3'-epimeric k-252a derivatives |
| 03/12/2003 | EP1036058B1 Adamantane derivatives |
| 03/12/2003 | EP1019426B1 Novel a1 adenosine receptor agonists and antagonists |
| 03/12/2003 | EP0994702B1 Medicament comprising adenosine |
| 03/12/2003 | EP0992239B1 Neuropeptide y receptor antagonist |
| 03/12/2003 | EP0991415B1 Orally administrable solid ribavirin dosage forms and process for making them |
| 03/12/2003 | EP0984773B1 Pharmaceutical formulation of omeprazole |
| 03/12/2003 | EP0983287B1 Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions |
| 03/12/2003 | EP0979098B1 Method of treating hyperprolactinemia and prolactinomas |
| 03/12/2003 | EP0970098B1 Anthracycline glycosides |
| 03/12/2003 | EP0964852B1 Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 03/12/2003 | EP0942899B1 Manufacturing process of metoprolol |
| 03/12/2003 | EP0937726B1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates |
| 03/12/2003 | EP0937074B1 Benzonaphthyridines as bronchial therapeutics |
| 03/12/2003 | EP0934064B1 Thrombin inhibitors |
| 03/12/2003 | EP0932396B1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 03/12/2003 | EP0923548B1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht 1a ligands |
| 03/12/2003 | EP0914138B1 Complex preparations characterised by a betain content |
| 03/12/2003 | EP0907372B1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma |
| 03/12/2003 | EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
| 03/12/2003 | EP0895478B1 Component b as cicatrizant |
| 03/12/2003 | EP0884950B1 A method of killing or inhibiting microbial cells |
| 03/12/2003 | EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof |
| 03/12/2003 | EP0871757B1 Conditionally replicating viral vectors and their use |
| 03/12/2003 | EP0869783B1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 03/12/2003 | EP0858335B1 2-alkylpyrrolidines |
| 03/12/2003 | EP0845984B1 Use of aminoadamantane compounds as immunoregulators |
| 03/12/2003 | EP0763039B1 42-rapamycin hydroxyester, process for its preparation and pharmaceutical compositions containing it |
| 03/12/2003 | EP0758243B1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa |
| 03/12/2003 | EP0742716B1 Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide |
| 03/12/2003 | EP0735879B1 Use of amino cyclodextrins for the aqueous solubilisation of dibenzazepines for use as an antiepileptic agent. |
| 03/12/2003 | EP0729459B1 Phenyl-alkyl imidazoles as h3-receptor antagonists |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/12/2003 | EP0661969B1 Taxol for treating lymphomas and breast cancer and for reducing multi-drug resistance to taxol |
| 03/12/2003 | EP0652754B1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| 03/12/2003 | CN1402793A Lentiviral triplex DNA, and vectors and recombinant cells contg. same |
| 03/12/2003 | CN1402786A Production of complex carbohydrates |
| 03/12/2003 | CN1402737A 6-mercapto-cyclodextrin derivs.: resersal agent for drug-induced neuromuscular block |
| 03/12/2003 | CN1402735A Novel androgens |
| 03/12/2003 | CN1402734A 3-methylene steroid deriv. |
| 03/12/2003 | CN1402732A Nb heterocyclic 8-modified adenosine derivs. |
| 03/12/2003 | CN1402730A Thiazolo (4,5-D) pyrimidine compounds |
| 03/12/2003 | CN1402729A Polycycloalkylpurines as adenosine receptor antagonists |
| 03/12/2003 | CN1402728A Method for producing epinastine hydrochloride in high-melting crystal modification |
| 03/12/2003 | CN1402727A Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring |
| 03/12/2003 | CN1402726A Bicyclic imidazo-5-yl-amine derivs. |
| 03/12/2003 | CN1402724A Thiazolidinedione derivs. as antidiabetic agents |
| 03/12/2003 | CN1402722A Arylamine derivs. and their use an anti-telomerase |
| 03/12/2003 | CN1402721A Benzoimidazole derivs. useful as antiproliferative agents |
| 03/12/2003 | CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants |
| 03/12/2003 | CN1402718A Neutralizing agent for toxin of microorganism belonging to genus clostridium |
| 03/12/2003 | CN1402717A Benzothiadiazine derivs., preparation method and pharmaceutical compositions contg. same |
| 03/12/2003 | CN1402716A Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators |
| 03/12/2003 | CN1402713A Control of arthropods in animals |
| 03/12/2003 | CN1402712A Novel heterocyclic compounds and salts thereof and medicinal use of same |
| 03/12/2003 | CN1402711A 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor |
| 03/12/2003 | CN1402710A Antipicornaviral compound and compositions, their pharmaceutical uses, and material for their synthesis |
| 03/12/2003 | CN1402709A 4-pyridinyl-N-acyl-L-phenylalanines |
| 03/12/2003 | CN1402706A Antidiabetic agents |
| 03/12/2003 | CN1402704A Comminuted form of (S)-2-ethoxy-3-[4-(2-{4-methane-sulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
| 03/12/2003 | CN1402703A Tri-substd. phenyl derivs. and analogues |
| 03/12/2003 | CN1402702A Beta 2-adrenergic receptor agonists |
| 03/12/2003 | CN1402643A Integrin-mediated drug targeting |
| 03/12/2003 | CN1402642A Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 03/12/2003 | CN1402639A Pharmaceutical combinations |
| 03/12/2003 | CN1402638A Method of treating substance addiction |
| 03/12/2003 | CN1402637A Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders |
| 03/12/2003 | CN1402636A Pharmaceutical formulations contg. zolmitriptan |
| 03/12/2003 | CN1402635A Agents for relieving carbonyl stress |
| 03/12/2003 | CN1402634A Use of beta-adrenoceptor antagonists for manufacture of medicament for treatment of disorders of outer retina |
| 03/12/2003 | CN1402633A Transdermal therapeutic system with improved stability and method for production thereof |
| 03/12/2003 | CN1402631A Extended release formulation of etodolac |
| 03/12/2003 | CN1402630A Novel pharmaceutical compositions |
| 03/12/2003 | CN1402616A Addition of tetracyclines to animal foodstuffs |
| 03/12/2003 | CN1401780A Method for preparing corydamine by biotransformation and use thereof in preparing analgesic |
| 03/12/2003 | CN1401657A Gene sequence and use of fish testicle development factor |
| 03/12/2003 | CN1401656A Gene sequence and use of fish testicle development factor |
| 03/12/2003 | CN1401655A Gene sequence and use of embryogenesis regulatory factor in hypophysis of rockfish |
| 03/12/2003 | CN1401654A 3,4'-5-trihydroxystlbenes compounds with functions of reducing pulmonary artery high pressure and improving respiration function |
| 03/12/2003 | CN1401653A Scrophularia oligose, production method and use thereof |
| 03/12/2003 | CN1401643A Process for preparing total jujuboflavone with calmative and hypnosis action |
| 03/12/2003 | CN1401638A Pyrazoles derivs., Pharmaceutical salt thereof and composition contg. same |
| 03/12/2003 | CN1401634A 4-guanidinobenzamides antifertility compounds |
| 03/12/2003 | CN1401621A Intermediate for preparing tricyclic compound and preparing method thereof |
| 03/12/2003 | CN1401386A Chinese medicine for removing intense heat from throat and dysphagia, and preparing process there |